Developer docs
API playgroundTry for free, no card

Search company profiles

Air Liquide

Full company profile

uuid00009v6

Namestring
Air Liquide
Legal namestring
L'AIR LIQUIDE S.A.
Websiteurl
airliquide.com
Company typeenum
Public
Founded yearint
1902
Descriptiontext

Air Liquide (EPA: AI) is a publicly traded French industrial gases and services company founded in 1902, headquartered in Paris. The company produces and distributes industrial gases — oxygen, nitrogen, argon, hydrogen, and CO2 — through on-site production plants, extensive pipeline networks (2,223 km in Benelux alone), and merchant distribution channels. Operations span 59 countries with approximately 65,000 employees serving 4.3 million customers and patients, generating approximately €27 billion in 2025 revenue with €3.5 billion net income.

The company operates across four primary segments: Industrial Manufacturing (steel, chemicals, refining, petrochemicals, cement), Electronics/Semiconductors (notably long-term contracts with SK hynix for HBM AI chip production and a Japanese semiconductor manufacturer in Hiroshima), Healthcare (medical gases to 20,000 hospitals and clinics, home healthcare for 2.3 million chronic disease patients, plus Seppic specialty ingredients), and Clean Mobility/Transportation (hydrogen refueling infrastructure including the TEAL Mobility joint venture with TotalEnergies). Air Liquide also operates Seppic for specialty ingredients and ALIAD as its corporate venture capital arm.

The business model centers on long-term take-or-pay contracts of 10-15 years with industrial customers, creating predictable recurring revenue streams. Pricing is not publicly disclosed and is contract-based. Capital intensity is high — €4.2 billion in investment decisions were made in 2025, supporting expansion into renewable hydrogen (Normand'Hy 200 MW, ELYgator 200 MW, Trailblazer 20 MW), carbon capture (Cryocap™ family serving cement, hydrogen, and industrial emissions), and AI-driven operational optimization under the ADVANCE 2025 transformation plan. The company divested its biogas production portfolio to Mobius Renewables in 2026 to focus capital on these higher-growth decarbonization and electronics verticals.

Short descriptiontext

Air Liquide is a Paris-based, publicly traded industrial gases and services company serving manufacturers, healthcare providers, and semiconductor producers across 59 countries through on-site plants, pipeline networks, and long-term take-or-pay contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
industrial gases, medical gases, air separation, carbon capture, hydrogen production
Industry1 code
1Air Separation (Oxygen/Nitrogen/Argon)
CodeIMAEACAAPrimaryYes
NAICS code2 codes
  • Industrial Gas Manufacturing32512
  • Industrial Gas Manufacturing325120
SIC code1 code
  • Industrial Inorganic Chemicals2810
Product category
Industrial Gases and Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Industrial Gases Sales
TypeSubscription Recurring
Description

Sale of industrial gases (oxygen, nitrogen, argon, hydrogen, CO₂) through on-site plants, pipeline networks, and merchant distribution. Revenue from long-term contracts with manufacturing customers.

airliquide.com
2Healthcare Services
TypeSubscription Recurring
Description

Medical gases supply to hospitals and healthcare facilities, home healthcare services for chronic conditions (respiratory diseases, diabetes), and specialty ingredients through Seppic subsidiary.

airliquide.com
3Green Bond Financing for Energy Transition Projects
TypeSubscription Recurring
Description

€500 million green bond issuance for low-carbon hydrogen, CO2 capture, and low-carbon air gases projects.

marketscreener.com
4Social Impact Programs
TypeSubscription Recurring
Description

Access Oxygen program providing oxygen therapy solutions to underserved healthcare markets, serving vulnerable populations.

engineeringnews.co.za
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Infrastructure, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1Cryocap™
Description

Proprietary carbon capture technology using cryogenic process for CO2 capture from industrial emissions

airliquide.com
+12 more records
Core offering1 text field

Air Liquide manufactures and distributes industrial and medical gases (oxygen, nitrogen, argon, hydrogen, helium, CO2) through on-site air separation units, pipeline networks, and merchant delivery to industrial manufacturers, healthcare facilities, and semiconductor companies. The company also provides proprietary carbon capture technologies (Cryocap family), large-scale renewable hydrogen production via PEM electrolysis projects (Normand'Hy, ELYgator), home healthcare services for chronic conditions, and specialty ingredients for pharmaceutical and cosmetic markets through its Seppic subsidiary.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • CO₂ emissions reduction of 13% vs 2020 baseline
+5 more records
Product overview1 text field

Air Liquide operates as a world leader in industrial gases, technologies, and services for industry and healthcare. The company offers a comprehensive portfolio spanning core industrial gases (oxygen, nitrogen, helium, argon, hydrogen, CO₂) produced through air separation units, advanced carbon capture technologies (Cryocap™ H₂, Cryocap™ OXY, Cryocap™ FG), and large-scale electrolyzer projects for renewable hydrogen (Normand'Hy, ELYgator, Trailblazer). The healthcare division provides medical gases, home healthcare services for chronic conditions, and specialty ingredients through Seppic. Key technologies include ammonia cracking and autothermal reforming for low-carbon hydrogen production. Major projects include Porthos CO₂ capture infrastructure and TEAL Mobility hydrogen refueling network with TotalEnergies. The company serves over 4 million customers and patients across 59 countries with approximately 65,000 employees.

Product and service7 records
1Industrial Gases Portfolio (Oxygen, Nitrogen, Argon, Hydrogen, Helium, CO2)
CategoryIndustrial Gases
Description

Core industrial gas offering of oxygen, nitrogen, helium, argon, hydrogen, and CO2 supplied globally to industrial manufacturers through on-site plants, pipeline networks, and merchant delivery under long-term take-or-pay contracts.

2Medical Gases for Hospitals
CategoryMedical Gases
Description

Pharmaceutical-quality medical gases (oxygen, anesthesia gases, etc.) supplied to operating theatres, intensive care units, emergency rooms, and respiratory wards, with associated services including inventory monitoring and staff training for 20,000 hospitals and clinics worldwide.

3Home Healthcare Services (VitalAire)
CategoryHome Healthcare Services
Description

Home-based healthcare services for chronic conditions including respiratory diseases, diabetes, and Parkinson's disease, providing equipment, therapies, and multidisciplinary care to 2.3 million home patients including the largest contract in Spain serving 90,000 respiratory patients.

4Seppic Specialty Ingredients
CategorySpecialty Ingredients
Description

Specialty ingredients including excipients and active ingredients developed for cosmetics, pharmaceutical, nutrition, and vaccine markets through scientific expertise, marketed under the Seppic brand.

5Cryocap H2 Carbon Capture Solution
CategoryCarbon Capture Technology
Description

Proprietary cryogenic technology for capturing CO2 from hydrogen production processes using natural gas, enabling low-carbon hydrogen manufacturing with reduced carbon footprint.

6Cryocap OXY Carbon Capture Solution
CategoryCarbon Capture Technology
Description

Carbon capture technology using cryogenic treatment to transform unavoidable industrial emissions into recoverable liquid CO2, enabling emissions reduction for hard-to-abate industrial processes.

7Cryocap FG Carbon Capture Solution for Cement
CategoryCarbon Capture Technology
Description

Cryogenic technology specifically designed to capture CO2 from cement industry flue gas, transforming industrial emissions into recoverable liquid CO2 at scale of 3,000 Nm3/h per unit.

Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierLong-Term Supply PartnershipTypeStrategic or Co-development PartnerAnnounced on2026-06-24
Description

Air Liquide Karabatan Tech Gases signed long-term agreement to supply nitrogen and dry compressed air to Silleno's polyethylene plant in Kazakhstan's Atyrau region. €70 million investment in two air separation units within National Industrial Petrochemical Technopark.

Strategic tierInnovation PartnershipTypeStrategic or Co-development PartnerAnnounced on2026-06-10
Description

Air Liquide deployed first industrial-scale Cryocap™ FG pilot unit at Holcim's CaptureLab in France specifically designed for cement sector decarbonization. The 3,000 Nm³/h unit tests carbon capture technology under real cement production conditions.

Strategic tierMajor Strategic ContractTypeStrategic or Co-development PartnerAnnounced on2026-06-03
Description

Air Liquide signed a long-term contract to supply industrial gases to SK hynix's new HBM chip packaging and testing facility (P&T7) in Cheongju, South Korea. Investment of nearly €200 million for dedicated nitrogen production unit.

Strategic tierStrategic Expansion In Indian MarketTypeStrategic or Co-development PartnerAnnounced on2025-10-27
Description

Air Liquide announced intention to acquire India's NovaAir to expand presence in the Indian industrial merchant market. The acquisition aims to strengthen Air Liquide's position in the Indian market and improve service across various industrial sectors.

Strategic tierFlagship Joint VentureTypeStrategic or Co-development PartnerAnnounced on2025-02-18
Description

Air Liquide and TotalEnergies formed a 50/50 joint venture to develop 380 MW of electrolysis capacity in France and Netherlands, representing over €1 billion investment in green hydrogen production. Also jointly developing over 100 hydrogen refueling stations through TEAL Mobility.

Strategic tierCore Technology PartnershipTypeStrategic or Co-development Partner
Description

Strategic partnership with Siemens Energy for PEM electrolyzer technology deployment in Normand'Hy 200 MW project and other large-scale hydrogen production initiatives. Leverages over 60 years of hydrogen expertise combined with Siemens Energy's electrolyzer technology.

Strategic tierHydrogen Ecosystem DevelopmentTypeStrategic or Co-development Partner
Description

Partnership to develop hydrogen ecosystem at Incheon Airport in South Korea, including two high-capacity hydrogen fueling stations operational since August 2021, with roadmap for broader hydrogen infrastructure expansion.

Strategic tierMajor Ccs ProjectTypeStrategic or Co-development Partner
Description

Air Liquide providing Cryocap technology for ACCSION carbon capture project at Aalborg Portland's Rørdal cement facility in Denmark. €2.2 billion government contract for capturing 1.25 million tonnes CO2 annually, with €220 million EU Innovation Fund backing.

Strategic tierCcs Infrastructure PartnerTypeStrategic or Co-development Partner
Description

Partnership with Harbour Energy for CO2 transport and storage infrastructure as part of carbon capture and storage projects, including Aalborg Portland ACCSION project.

Strategic tierHydrogen Fueling PartnershipTypeStrategic or Co-development Partner
Description

Air Liquide providing hydrogen fuel supply for Toyota's hydrogen fuel cell-powered Class 8 trucks deployment at North America Parts Center California campus, with fueling operations beginning later this year.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

China's largest independent industrial gas supplier with on-site and merchant offerings. Comparable product set to Air Liquide's industrial gases business but primarily serves Chinese onshore customers.

TypeDirect peer
Description

Global industrial gas major headquartered in the UK/Ireland with comparable product portfolio (atmospheric gases, hydrogen, helium) and on-site/pipeline delivery model. Closest direct competitor across virtually all of Air Liquide's geographies and end-markets, including electronics and healthcare gases.

TypeDirect peer
Description

US-based industrial gas and hydrogen heavyweight. Direct overlap in merchant gases, on-site supply, and large hydrogen/CCS projects. Competes head-to-head for major semiconductor and industrial contracts and pursues similar blue/green hydrogen strategies.

TypeDirect peer
Description

Japan-headquartered industrial gas company and the fourth global player. Direct competitor in semiconductor ultra-pure gases, particularly in Japan, South Korea, and Taiwan where it competes with Air Liquide for fab supply contracts.

TypeDirect peer
Description

Privately-held German industrial gas producer (post-CVC partnership) operating in Europe, Americas, and Asia. Directly comparable merchant and on-site gas offerings; a long-standing competitor especially in Europe and the Americas.

TypeDirect peer
Description

Japanese industrial gas and hydrogen player with strong presence in hydrogen liquefaction, transport, and refueling infrastructure. Comparable in hydrogen mobility and electronics gases, particularly within Asia.

TypeDirect peer
Description

Italian-headquartered industrial and medical gas supplier active across Europe. Direct competitor in industrial merchant gases, home healthcare, and medical gases; comparable European footprint though smaller scale.

TypeOthers
Description

US cryogenic equipment manufacturer supplying air separation, hydrogen liquefaction, and CO₂ capture hardware. Adjacent rather than directly competitive, but its equipment is used by Air Liquide and other gas majors.

TypeEmerging player
Description

Japanese chemicals and electronic materials producer with adjacent specialty gas offerings (electronic gases, hydrogen). Partial overlap with Air Liquide's electronics gas segment in Japan and Asia.

TypeOthers
Description

Engineering arm of Linde that builds ASUs, hydrogen plants, and CO₂ capture units. Direct competitor in technology licensing and EPC for industrial gas production assets that Air Liquide also designs and builds internally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A47 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Air Liquide

Industrial Gases and Servicesairliquide.com

Air Liquide is a Paris-based, publicly traded industrial gases and services company serving manufacturers, healthcare providers, and semiconductor producers across 59 countries through on-site plants, pipeline networks, and long-term take-or-pay contracts.

What Air Liquide does

Air Liquide (EPA: AI) is a publicly traded French industrial gases and services company founded in 1902, headquartered in Paris. The company produces and distributes industrial gases — oxygen, nitrogen, argon, hydrogen, and CO2 — through on-site production plants, extensive pipeline networks (2,223 km in Benelux alone), and merchant distribution channels. Operations span 59 countries with approximately 65,000 employees serving 4.3 million customers and patients, generating approximately €27 billion in 2025 revenue with €3.5 billion net income.

The company operates across four primary segments: Industrial Manufacturing (steel, chemicals, refining, petrochemicals, cement), Electronics/Semiconductors (notably long-term contracts with SK hynix for HBM AI chip production and a Japanese semiconductor manufacturer in Hiroshima), Healthcare (medical gases to 20,000 hospitals and clinics, home healthcare for 2.3 million chronic disease patients, plus Seppic specialty ingredients), and Clean Mobility/Transportation (hydrogen refueling infrastructure including the TEAL Mobility joint venture with TotalEnergies). Air Liquide also operates Seppic for specialty ingredients and ALIAD as its corporate venture capital arm.

The business model centers on long-term take-or-pay contracts of 10-15 years with industrial customers, creating predictable recurring revenue streams. Pricing is not publicly disclosed and is contract-based. Capital intensity is high — €4.2 billion in investment decisions were made in 2025, supporting expansion into renewable hydrogen (Normand'Hy 200 MW, ELYgator 200 MW, Trailblazer 20 MW), carbon capture (Cryocap™ family serving cement, hydrogen, and industrial emissions), and AI-driven operational optimization under the ADVANCE 2025 transformation plan. The company divested its biogas production portfolio to Mobius Renewables in 2026 to focus capital on these higher-growth decarbonization and electronics verticals.

Air Liquide firmographics

Firmographics
Name
Air Liquide
Legal name
L'AIR LIQUIDE S.A.
Website
https://airliquide.com
Company type
Public
Founded year
1902
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Air Liquide is a Paris-based, publicly traded industrial gases and services company serving manufacturers, healthcare providers, and semiconductor producers across 59 countries through on-site plants, pipeline networks, and long-term take-or-pay contracts.
Ownership category
akta.pro rank

Air Liquide industry classification

Industry
Product category
Industrial Gases and Services
NAICS
Industrial Gas Manufacturing (32512), Industrial Gas Manufacturing (325120)
SIC
Industrial Inorganic Chemicals (2810)
akta.pro primary industry
Air Separation (Oxygen/Nitrogen/Argon) (IMAEACAA)

Keywords

  • Industrial gases
  • Medical gases
  • Air separation
  • Carbon capture
  • Hydrogen production

Where Air Liquide is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices9 records

Markets served

Air Liquide business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Infrastructure, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Industrial Gases Sales: Sale of industrial gases (oxygen, nitrogen, argon, hydrogen, CO₂) through on-site plants, pipeline networks, and merchant distribution. Revenue from long-term contracts with manufacturing customers.
  2. Healthcare Services: Medical gases supply to hospitals and healthcare facilities, home healthcare services for chronic conditions (respiratory diseases, diabetes), and specialty ingredients through Seppic subsidiary.
  3. Green Bond Financing for Energy Transition Projects: €500 million green bond issuance for low-carbon hydrogen, CO2 capture, and low-carbon air gases projects.
  4. Social Impact Programs: Access Oxygen program providing oxygen therapy solutions to underserved healthcare markets, serving vulnerable populations.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Air Liquide product offering

Product offering

Core offering

Air Liquide manufactures and distributes industrial and medical gases (oxygen, nitrogen, argon, hydrogen, helium, CO2) through on-site air separation units, pipeline networks, and merchant delivery to industrial manufacturers, healthcare facilities, and semiconductor companies. The company also provides proprietary carbon capture technologies (Cryocap family), large-scale renewable hydrogen production via PEM electrolysis projects (Normand'Hy, ELYgator), home healthcare services for chronic conditions, and specialty ingredients for pharmaceutical and cosmetic markets through its Seppic subsidiary.

Product overview

Air Liquide operates as a world leader in industrial gases, technologies, and services for industry and healthcare. The company offers a comprehensive portfolio spanning core industrial gases (oxygen, nitrogen, helium, argon, hydrogen, CO₂) produced through air separation units, advanced carbon capture technologies (Cryocap™ H₂, Cryocap™ OXY, Cryocap™ FG), and large-scale electrolyzer projects for renewable hydrogen (Normand'Hy, ELYgator, Trailblazer). The healthcare division provides medical gases, home healthcare services for chronic conditions, and specialty ingredients through Seppic. Key technologies include ammonia cracking and autothermal reforming for low-carbon hydrogen production. Major projects include Porthos CO₂ capture infrastructure and TEAL Mobility hydrogen refueling network with TotalEnergies. The company serves over 4 million customers and patients across 59 countries with approximately 65,000 employees.

Differentiator

Problem solved

Functional benefit

Brands

  • Cryocap™: Proprietary carbon capture technology using cryogenic process for CO2 capture from industrial emissions
  • Cryocap™ H₂
  • Cryocap™ OXY
  • Cryocap™ FG
  • Value-Based Healthcare
  • Seppic
  • VitalAire
  • ALIAD
  • Normand'Hy
  • ELYgator
  • Trailblazer
  • Access Oxygen
  • TEAL Mobility

Products and services

  • Industrial Gases Portfolio (Oxygen, Nitrogen, Argon, Hydrogen, Helium, CO2) Core industrial gas offering of oxygen, nitrogen, helium, argon, hydrogen, and CO2 supplied globally to industrial manufacturers through on-site plants, pipeline networks, and merchant delivery under long-term take-or-pay contracts.
  • Medical Gases for Hospitals Pharmaceutical-quality medical gases (oxygen, anesthesia gases, etc.) supplied to operating theatres, intensive care units, emergency rooms, and respiratory wards, with associated services including inventory monitoring and staff training for 20,000 hospitals and clinics worldwide.
  • Home Healthcare Services (VitalAire) Home-based healthcare services for chronic conditions including respiratory diseases, diabetes, and Parkinson's disease, providing equipment, therapies, and multidisciplinary care to 2.3 million home patients including the largest contract in Spain serving 90,000 respiratory patients.
  • Seppic Specialty Ingredients Specialty ingredients including excipients and active ingredients developed for cosmetics, pharmaceutical, nutrition, and vaccine markets through scientific expertise, marketed under the Seppic brand.
  • Cryocap H2 Carbon Capture Solution Proprietary cryogenic technology for capturing CO2 from hydrogen production processes using natural gas, enabling low-carbon hydrogen manufacturing with reduced carbon footprint.
  • Cryocap OXY Carbon Capture Solution Carbon capture technology using cryogenic treatment to transform unavoidable industrial emissions into recoverable liquid CO2, enabling emissions reduction for hard-to-abate industrial processes.
  • Cryocap FG Carbon Capture Solution for Cement Cryogenic technology specifically designed to capture CO2 from cement industry flue gas, transforming industrial emissions into recoverable liquid CO2 at scale of 3,000 Nm3/h per unit.

Quantifiable outcome

  • CO₂ emissions reduction of 13% vs 2020 baseline
  • +5 more outcomes

Companies that use Air Liquide

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Air Liquide technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Air Liquide partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered long-term supply partnership, innovation partnership, major strategic contract, strategic expansion in indian market, flagship joint venture, core technology partnership, hydrogen ecosystem development, major ccs project, ccs infrastructure partner and hydrogen fueling partnership.

  • Sillenolong-term supply partnershipStrategic or Co-development Partner · 24 June 2026Air Liquide Karabatan Tech Gases signed long-term agreement to supply nitrogen and dry compressed air to Silleno's polyethylene plant in Kazakhstan's Atyrau region. €70 million investment in two air separation units within National Industrial Petrochemical Technopark.
  • Holciminnovation partnershipStrategic or Co-development Partner · 10 June 2026Air Liquide deployed first industrial-scale Cryocap™ FG pilot unit at Holcim's CaptureLab in France specifically designed for cement sector decarbonization. The 3,000 Nm³/h unit tests carbon capture technology under real cement production conditions.
  • SK hynixmajor strategic contractStrategic or Co-development Partner · 3 June 2026Air Liquide signed a long-term contract to supply industrial gases to SK hynix's new HBM chip packaging and testing facility (P&T7) in Cheongju, South Korea. Investment of nearly €200 million for dedicated nitrogen production unit.
  • NovaAirstrategic expansion in indian marketStrategic or Co-development Partner · 27 October 2025Air Liquide announced intention to acquire India's NovaAir to expand presence in the Indian industrial merchant market. The acquisition aims to strengthen Air Liquide's position in the Indian market and improve service across various industrial sectors.
  • TotalEnergiesflagship joint ventureStrategic or Co-development Partner · 18 February 2025Air Liquide and TotalEnergies formed a 50/50 joint venture to develop 380 MW of electrolysis capacity in France and Netherlands, representing over €1 billion investment in green hydrogen production. Also jointly developing over 100 hydrogen refueling stations through TEAL Mobility.
  • Siemens Energycore technology partnershipStrategic or Co-development PartnerStrategic partnership with Siemens Energy for PEM electrolyzer technology deployment in Normand'Hy 200 MW project and other large-scale hydrogen production initiatives. Leverages over 60 years of hydrogen expertise combined with Siemens Energy's electrolyzer technology.
  • Airbus/Korean Air/Incheon International Airport Corporationhydrogen ecosystem developmentStrategic or Co-development PartnerPartnership to develop hydrogen ecosystem at Incheon Airport in South Korea, including two high-capacity hydrogen fueling stations operational since August 2021, with roadmap for broader hydrogen infrastructure expansion.
  • Aalborg Portlandmajor ccs projectStrategic or Co-development PartnerAir Liquide providing Cryocap technology for ACCSION carbon capture project at Aalborg Portland's Rørdal cement facility in Denmark. €2.2 billion government contract for capturing 1.25 million tonnes CO2 annually, with €220 million EU Innovation Fund backing.
  • Harbour Energyccs infrastructure partnerStrategic or Co-development PartnerPartnership with Harbour Energy for CO2 transport and storage infrastructure as part of carbon capture and storage projects, including Aalborg Portland ACCSION project.
  • Toyota Motor North Americahydrogen fueling partnershipStrategic or Co-development PartnerAir Liquide providing hydrogen fuel supply for Toyota's hydrogen fuel cell-powered Class 8 trucks deployment at North America Parts Center California campus, with fueling operations beginning later this year.

Scale indicators19 records

Recent moves9 records

Expansion highlights6 records

Air Liquide competitors and assessment

Company assessment

Regional players

  • Yingde Gases Group: China's largest independent industrial gas supplier with on-site and merchant offerings. Comparable product set to Air Liquide's industrial gases business but primarily serves Chinese onshore customers.

Direct peers

  • Linde plc: Global industrial gas major headquartered in the UK/Ireland with comparable product portfolio (atmospheric gases, hydrogen, helium) and on-site/pipeline delivery model. Closest direct competitor across virtually all of Air Liquide's geographies and end-markets, including electronics and healthcare gases.
  • Air Products and Chemicals: US-based industrial gas and hydrogen heavyweight. Direct overlap in merchant gases, on-site supply, and large hydrogen/CCS projects. Competes head-to-head for major semiconductor and industrial contracts and pursues similar blue/green hydrogen strategies.
  • Nippon Sanso Holdings (Taiyo Nippon Sanso): Japan-headquartered industrial gas company and the fourth global player. Direct competitor in semiconductor ultra-pure gases, particularly in Japan, South Korea, and Taiwan where it competes with Air Liquide for fab supply contracts.
  • Messer Group: Privately-held German industrial gas producer (post-CVC partnership) operating in Europe, Americas, and Asia. Directly comparable merchant and on-site gas offerings; a long-standing competitor especially in Europe and the Americas.
  • Iwatani Corporation: Japanese industrial gas and hydrogen player with strong presence in hydrogen liquefaction, transport, and refueling infrastructure. Comparable in hydrogen mobility and electronics gases, particularly within Asia.
  • SOL Group: Italian-headquartered industrial and medical gas supplier active across Europe. Direct competitor in industrial merchant gases, home healthcare, and medical gases; comparable European footprint though smaller scale.

Others

  • Chart Industries: US cryogenic equipment manufacturer supplying air separation, hydrogen liquefaction, and CO₂ capture hardware. Adjacent rather than directly competitive, but its equipment is used by Air Liquide and other gas majors.
  • Linde Engineering (part of Linde plc): Engineering arm of Linde that builds ASUs, hydrogen plants, and CO₂ capture units. Direct competitor in technology licensing and EPC for industrial gas production assets that Air Liquide also designs and builds internally.

Emerging players

  • Showa Denko: Japanese chemicals and electronic materials producer with adjacent specialty gas offerings (electronic gases, hydrogen). Partial overlap with Air Liquide's electronics gas segment in Japan and Asia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Air Liquide social profiles

Digital presence

Air Liquide compliance and trust

Trust signal

Compliance1 record

Air Liquide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Air Liquide leadership team

Management profile

Number of profiles

Profiles11 records

Air Liquide subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Air Liquide funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Air Liquide M&A and investment

M&A and investment

M&A47 records

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Air Liquide

What does Air Liquide do?

Air Liquide manufactures and distributes industrial and medical gases (oxygen, nitrogen, argon, hydrogen, helium, CO2) through on-site air separation units, pipeline networks, and merchant delivery to industrial manufacturers, healthcare facilities, and semiconductor companies. The company also provides proprietary carbon capture technologies (Cryocap family), large-scale renewable hydrogen production via PEM electrolysis projects (Normand'Hy, ELYgator), home healthcare services for chronic conditions, and specialty ingredients for pharmaceutical and cosmetic markets through its Seppic subsidiary.

Is Air Liquide a public or private company?

Air Liquide is a public company. It is classified as public and is currently operating.

When was Air Liquide founded?

Air Liquide was founded in 1902. It employs 5,001 to 10,000 people.

Where is Air Liquide based?

Air Liquide is headquartered in Paris, France, in the Europe region.

How does Air Liquide make money?

Four revenue lines are on record. Industrial Gases Sales are the primary driver. The others are healthcare Services, green Bond Financing for Energy Transition Projects and social Impact Programs.

Who are Air Liquide's main competitors?

Yingde Gases Group is listed as a regional player. Direct peers are Linde plc, Air Products and Chemicals, Nippon Sanso Holdings (Taiyo Nippon Sanso), Messer Group, Iwatani Corporation and SOL Group. Others are Chart Industries and Linde Engineering (part of Linde plc). Showa Denko is listed as an emerging player.

Does Air Liquide have an API?

No public API is recorded for Air Liquide.

What industry is Air Liquide in?

Air Liquide's product category is Industrial Gases and Services. Its primary akta.pro industry code is IMAEACAA, Air Separation (Oxygen/Nitrogen/Argon). Its NAICS code is 32512 and its SIC code is 2810.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACAir Liquide to build new Air Separation Unit at its Fairfield facility in New South WalesAir Liquide announced an investment to build and operate a new Air Separation Unit at its Fairfield facility in New South Wales, Australia. The unit will produce nitrogen and oxygen for industrial and medical sectors, with startup expected in 2028.MarketScreenerElliott confirms position in Air Liquide and wants to accelerate share buybacksElliott confirmed its position in Air Liquide, calling the new strategic plan a positive first step. The fund sees the buyback timetable as a friction point, with Moody's confirming the A2 rating only if the program runs between 2027-2028. Elliott awaits the October 29 release before adjusting forecasts.FinanzNachrichten.deDZ BANK stuft AIR LIQUIDE(L) auf 'Kaufen'DZ Bank raised its fair value estimate for Air Liquide to 210 euros from 200, keeping the 'Buy' rating. The gas company offers higher margins, rising EPS, and attractive capital returns, with semiconductor capacity expansion driving demand for specialty gases.BloombergAir Liquide Sells Debt at Better Rate Than French GovernmentAir Liquide SA attracted strong demand for a €2 billion bond offering, drawing over €13.1 billion in investor orders. The industrial-gas maker's two-year floating-rate note and five- and 10-year fixed-rate tranches were priced at lower yields than French government bonds affected by fiscal and political turmoil.QuartzAir Liquide launches €4 billion buyback, targets 2030 growthAir Liquide unveiled its BEYOND plan with a €4 billion buyback over 2027-2028 and targets 10% annual recurring EPS growth. The company commits over €40 billion in capital, prioritizing electronics, AI, energy, healthcare, and space, with the Americas expected to surpass Europe.Les EchosSous pression, Air Liquide change d'étatAir Liquide announced a 4 billion euro share buyback under its 'Beyond 2030' plan, a first for the group. The stock rose up to 4% in trading. The role of American investor Elliott, which recently entered the capital, remains unclear.FinanzNachrichten.deAktien Europa: Börsen der Euroregion schwächeln - Gewinne in Zürich und LondonEurozone stocks fell on Monday after modest gains, with the EuroStoxx 50 down 0.3% to 6,217 points, while Swiss and London indices rose. High French bond yields and Spain's election uncertainty weighed on sentiment, while Schneider Electric's acquisition of PTC dragged the EuroStoxx. Air Liquide and Ithaca Energy led gains.ReutersAir Liquide monte en Bourse après son nouveau plan stratégiqueAir Liquide announced a 5% average annual revenue growth forecast through 2030 and a €4 billion share buyback program. The company also targets improving its operating margin from 400 to 600 basis points over 2026-2030, with a capital allocation of over €40 billion.MarketScreenerAir Liquide launches strategic plan and historic share buybackAir Liquide unveiled its Beyond strategic plan through 2030, targeting growth from energy transition, AI-driven electronics, home healthcare, and space. The company plans €40bn in capital allocation, with over half for industrial investments and acquisitions, and launched a €4bn share buyback for 2027-2028. Jefferies maintains a buy rating with a €204 price target.FinanzNachrichten.deBERNSTEIN RESEARCH stuft AIR LIQUIDE(L) auf 'Outperform'Bernstein Research kept Air Liquide on 'Outperform' with a €192 price target. The analyst cited a capital market day signaling growth acceleration for the gas company.